These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 9810173)
1. Lauren's and Goseki's grade distribution does not change along with the progression from an early to advanced gastric carcinoma. Stachura J; Popiela T; Kulig J; Urbańczyk K; Heitzman J Pol J Pathol; 1998; 49(3):151-3. PubMed ID: 9810173 [TBL] [Abstract][Full Text] [Related]
2. Preferential overexpression of CD44v5 in advanced gastric carcinoma Goseki grades I and III. Stachura J; Krzeszowiak A; Popiela T; Urbańczyk K; Pituch-Noworolska A; Wieckiewicz J; Zembala M Pol J Pathol; 1999; 50(3):155-61. PubMed ID: 10624117 [TBL] [Abstract][Full Text] [Related]
3. [Prognostic value of histologic classifications of advanced stomach cancer: comparative study of Lauren's and Goseki's classifications]. Guglielmi A; de Manzoni G; Tomezzoli A; Ricci F; Pelosi G; Laterza E; Di Leo A; Bonfiglio M Chir Ital; 1997; 49(3):45-9. PubMed ID: 9612652 [TBL] [Abstract][Full Text] [Related]
4. How do gastric carcinoma classification systems relate to mucin expression patterns? An immunohistochemical analysis in a series of advanced gastric carcinomas. Gürbüz Y; Kahlke V; Klöppel G Virchows Arch; 2002 May; 440(5):505-11. PubMed ID: 12021925 [TBL] [Abstract][Full Text] [Related]
5. Gastric cancer: correlation between clinicopathological factors and survival of patients. II. Lazăr D; Tăban S; Sporea I; Dema A; Cornianu M; Lazăr E; Goldiş A; Vernic C Rom J Morphol Embryol; 2009; 50(2):185-94. PubMed ID: 19434309 [TBL] [Abstract][Full Text] [Related]
6. Lack of prognostic significance in Goseki grading of gastric carcinoma. Ventura L; Chiominto A; Discepoli S; Ventura T; Di Giacomo C; Leocata P J Exp Clin Cancer Res; 2002 Jun; 21(2):225-7. PubMed ID: 12148582 [TBL] [Abstract][Full Text] [Related]
7. [Correlation of histological classifications of gastric carcinomas with location and prognosis]. Calli Demirkan N; Tunçyürek M; Ugur Ertan E; Bülent Alkanat M; Içöz G Gastroenterol Clin Biol; 2002; 26(6-7):610-5. PubMed ID: 12193861 [TBL] [Abstract][Full Text] [Related]
8. [Clinical importance of histological typing of gastric carcinoma (author's transl)]. Giedl J MMW Munch Med Wochenschr; 1980 Feb; 122(6):205-8. PubMed ID: 6767957 [TBL] [Abstract][Full Text] [Related]
9. Gastric cancer with special references to WHO and Laurén's classifications: glycogen and triacylglycerol concentrations in the tumor. Namiot Z; Stasiewicz J; Szałaj W; Skwarski L; Jodczyk J; Górski J Neoplasma; 1989; 36(3):363-8. PubMed ID: 2739816 [TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of p53 expression and cell proliferation in gastric carcinomas. An immunohistochemical study. Gonda G; Bajtai A; Nagy P; Szántó I; Kiss J Hepatogastroenterology; 2004; 51(55):273-6. PubMed ID: 15011884 [TBL] [Abstract][Full Text] [Related]
11. Relationship between immunoexpression of mucin peptide cores MUC1 and MUC2 and Lauren's histologic subtypes of gastric carcinomas. Barresi V; Vitarelli E; Grosso M; Tuccari G; Barresi G Eur J Histochem; 2006; 50(4):301-9. PubMed ID: 17213039 [TBL] [Abstract][Full Text] [Related]
12. [Gastric carcinoma: a histopathological study of 705 cases]. Leocata P; Ventura L; Giunta M; Guadagni S; Fortunato C; Discepoli S; Ventura T Ann Ital Chir; 1998; 69(3):331-7. PubMed ID: 9835105 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical evaluation of Ki-67, PCNA and MCM2 proteins proliferation index (PI) in advanced gastric cancer. Czyzewska J; Guzińska-Ustymowicz K; Pryczynicz A; Kemona A; Bandurski R Folia Histochem Cytobiol; 2009; 47(2):289-96. PubMed ID: 19995716 [TBL] [Abstract][Full Text] [Related]
14. Gastric cancer: correlation between clinicopathological factors and survival of patients (III). Lazăr D; Tăban S; Sporea I; Dema A; Cornianu M; Lazăr E; Goldiş A; Vernic C Rom J Morphol Embryol; 2009; 50(3):369-79. PubMed ID: 19690762 [TBL] [Abstract][Full Text] [Related]
15. Histological grading in gastric cancer by Goseki classification: correlation with histopathological subtypes and prognosis. Mönig S; Baldus SE; Collet PH; Zirbes TK; Bollschweiler E; Thiele J; Dienes HP; Hölscher AH Anticancer Res; 2001; 21(1B):617-20. PubMed ID: 11299815 [TBL] [Abstract][Full Text] [Related]
16. Tenascin expression in gastric cancer with special emphasis on the WHO-, Lauren-, and Goseki-classifications. Zirbes TK; Baldus SE; Moenig SP; Schmitz K; Thiele J; Holscher AH; Dienes HP Int J Mol Med; 1999 Jul; 4(1):39-42. PubMed ID: 10373635 [TBL] [Abstract][Full Text] [Related]
17. Intestinal type: diffuse type ratio of gastric carcinoma in a Mexican population. Mohar A; Suchil-Bernal L; Hernández-Guerrero A; Podolsky-Rapoport I; Herrera-Goepfert R; Mora-Tiscareño A; Aiello-Crocifoglio V J Exp Clin Cancer Res; 1997 Jun; 16(2):189-94. PubMed ID: 9261746 [TBL] [Abstract][Full Text] [Related]
18. Pathology and prognosis of gastric carcinoma: well versus poorly differentiated type. Adachi Y; Yasuda K; Inomata M; Sato K; Shiraishi N; Kitano S Cancer; 2000 Oct; 89(7):1418-24. PubMed ID: 11013353 [TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic characteristics of replication error-positive gastric carcinoma. Kang GH; Yoon GS; Lee HK; Kwon YM; Ro JY Mod Pathol; 1999 Jan; 12(1):15-20. PubMed ID: 9950157 [TBL] [Abstract][Full Text] [Related]
20. Subcellular localization of MUC1 recognized by a monoclonal antibody MY.1E12 correlates with postsurgical prognosis in differentiated-type gastric carcinomas of stage II and III. Shinozaki E; Adachi S; Shoda J; Kawamoto T; Suzuki H; Irimura T; Ohkohchi N Int J Oncol; 2004 Nov; 25(5):1257-65. PubMed ID: 15492813 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]